Found: 1
Select item for more details and to access through your institution.
The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 5, p. 1, doi. 10.1007/s00520-024-08498-z
- By:
- Publication type:
- Article